top of page
wave.jpg

News

  • Twitter
  • LinkedIn

You can stay up to date with the formal and informal 'goings on' at RAPIvD by following us on LinkedIn and Twitter. 

If it's more formal company news and developments that you're looking for. Bingo, you're here.

News release.png

07:02:2023

RAPIvD strengthens ties with Stream Bio

RAPIvD has signed a partnership agreement with Stream Bio to use their conjugated polymer nanoparticles (CPNs) in lateral flow assay development projects.

Download news release (.pdf)

News release.png

06:01:2023

Influenza A/B Test Development Enters Optimisation Phase

Rapid in vitro diagnostics specialist, RAPIvD Ltd has announced successful prototype tests in developing a rapid multiplexed influenza A/B lateral flow assay.

Download news release (.pdf)

News release.png

09:12:2022

RAPIvD achieves ISO 13485 certification

Rapid in vitro diagnostics specialist, RAPIvD Ltd has announced that it has achieved certification for meeting ISO 13485 medical devices standards for ‘contract development and manufacture of lateral flow assays for IVD’.

Download news release (.pdf)

News release.png

08:12:2022

Gemina Labs buys 19% stake in RAPIvD

The shareholders of rapid in vitro diagnostics specialist, RAPIvD Ltd have announced the sale of a 19% stake in the business to the publicly listed Vancouver-based company, Gemina Labs.

Download news release (.pdf)

bottom of page